Atherosclerosis: X

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysiology and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Prevention of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagnostics Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translational Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Medicine-Cardiology and Cardiovascular Medicine

主编 Jan Borén出版商官网

编委会国家分布：中国大陆 2 位（约 1%）；主要国家 荷兰 20、德国 18、意大利 18、美国 16、澳大利亚 15（共 172 位编委标注了国家） 编委会 ↗出版商官网 · 2026-09-30

中科院期刊分区表

数据库收录

ScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子（出版商公布）

7.1出版商官网 · 2026-09-30

CiteScore 2026-06

0.3LetPub · 2026-09-13

CiteScore（出版商公布）

10.2出版商官网 · 2026-09-30

SJR 2026-06

0.17LetPub · 2026-09-13

SNIP 2026-06

0.17LetPub · 2026-09-13

h-index

0OpenAlex · 2026-10-01

i10-index

0OpenAlex · 2026-10-01

两年平均被引

0OpenAlex · 2026-10-01

Gold OA 文章占比

0%LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

各来源数据

投稿到首次决定

7 天出版商官网 · 2026-09-30

外审后首次决定

41 天出版商官网 · 2026-09-30

投稿到接收

110 天出版商官网 · 2026-09-30

接收到发表

3 天出版商官网 · 2026-09-30

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Elsevier

ISSN

2590-1354

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网